Cancel
Guo-Liang Yu
Co-Founder, Executive Director, Chairman and Chief Executive Officer
@
Apollomics
3fd41btfx.6z@z06d09vw1kd51.kbz
Sign up to see email
Known information
- Obtained a Ph.D. in molecular biology from the University of California, Berkeley
- Has over 31 years of experience in the pharmaceutical industry and academic research
- Is a serial entrepreneur who has co-founded over ten startup companies in biotech and healthcare sectors
- Previously served as the executive chairman of Crown Bioscience International
- Was a venture partner with OrbiMed Asia Limited
- Served as the founding president of the Chinese Biopharmaceutical Association USA, Inc.
- Is a board member of the Ray Wu Memorial Fund
- Currently a member of the Board of Directors of Immune-Onc Therapeutics, Inc., Zhejiang Innoforce Pharmaceuticals Co., and Inmagene Biopharmaceuticals
About Apollomics
Apollomics is a biopharmaceutical company focused on developing innovative oncology therapies, including targeted treatments and immune system enhancers, with operations in the U.S., China, and Australia.
Report inaccurate information
